PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

UT Southwestern study to determine whether leptin helps type 1 diabetes patients

2010-10-11
(Press-News.org) DALLAS – Oct. 11, 2010 – A clinical trial at UT Southwestern Medical Center aims to determine whether adding the hormone leptin to standard insulin therapy might help rein in the tumultuous blood-sugar levels of people with type 1 (insulin-dependent) diabetes.

This is the first type 1 diabetes treatment trial involving leptin, which is naturally produced by fat cells and involved in body-weight regulation. For this study, UT Southwestern researchers will be using metreleptin, a slightly modified form of the hormone that has been well-tolerated in other clinical trials.

"Leptin has been very effective in improving diabetes in patients with lipodystrophies who have extreme lack of body fat, and recently leptin therapy has helped improve blood sugar control in animal models of type 1 diabetes," said Dr. Abhimanyu Garg, professor of internal medicine and principal investigator of the trial. "Although we have no assurances that this will work in humans, we hope that the addition of leptin will be beneficial to patients with type 1 diabetes."

The phase 1 study also is designed to evaluate the safety and tolerability of adding leptin to a diabetes treatment regimen.

In type 1 diabetes, formerly known as juvenile-onset diabetes, the pancreatic beta cells that produce insulin are destroyed by an autoimmune process. Type 1 diabetics must regiment their diets and take insulin multiple times a day to control blood-sugar levels and prevent diabetic coma. The autoimmune disease, for which there is no cure, affects about 1 million people in the U.S.

Insulin treatment has been the gold standard for type 1 diabetes since its discovery in 1922. The laboratory of Dr. Roger Unger, professor of internal medicine at UT Southwestern, previously found that insulin's benefit resulted from its suppression of glucagon, a hormone produced by the pancreas that raises blood-sugar levels in healthy individuals.

More recently, Dr. Unger's lab, using mouse models of type 1 diabetes, found that administering leptin instead of insulin resulted in better management of blood-sugar variability and lipogenesis, the conversion of simple sugars into fatty acids.

For the clinical study, 12 to 15 participants will add leptin twice a day to their standard insulin therapy over a five-month period. The trial will last a total of seven months and will include 11 visits – an initial screening, four inpatient visits and six outpatient evaluations – to UT Southwestern. The first inpatient visit will last a minimum of four days; the others will take two days each.

To be eligible for the initial screening, prospective trial participants must be between 18 and 50 years of age, have a body mass index (BMI) less than 25, and have been diagnosed with type 1 diabetes. BMI is a weight-to-height ratio commonly used in doctors' offices to gauge obesity. A normal BMI is between 18.5 and 25.

Dr. Gregory Clark, assistant professor of internal medicine and a trial investigator, said one incentive to take part in the trial is that participants might lose weight.

"Leptin is known to decrease appetite, so it's likely that participants won't be as hungry," he said. "We hope that the addition of leptin also reduces the blood levels of cholesterol, which increase the risk of coronary heart disease, one of the long-term complications of diabetes."

Dr. Unger emphasized that the goal is not to find a replacement for insulin, but to obtain stable glucose levels, something that has eluded monotherapy with insulin. The theory is that adding leptin might allow a substantial reduction in insulin dose and lower the risk of low blood glucose levels.

"If it works in humans as well as it does in rodents, it will be a major step forward," said Dr. Unger. "In rodents, it eliminated the wide swings in glucose that occur with insulin alone and lowered indices of cholesterol formation. The hope is that it will improve both short- and long-term quality of life for patients with type 1 diabetes."

### Other UT Southwestern researchers involved in the trial include Dr. Pablo Mora, associate professor of internal medicine, and Dr. Zahid Ahmad, postdoctoral trainee in internal medicine.

For more information about the clinical trial, call 214-648-3621 or 214-648-9296.

Visit www.utsouthwestern.org/endocrinology to learn more about UT Southwestern's clinical services in endocrinology, including diabetes.

This news release is available on our World Wide Web home page at http://www.utsouthwestern.edu/home/news/index.html

To automatically receive news releases from UT Southwestern via e-mail, subscribe at www.utsouthwestern.edu/receivenews

END



ELSE PRESS RELEASES FROM THIS DATE:

Study finds monarch butterflies use medicinal plants to treat offspring for disease

2010-10-11
Monarch butterflies appear to use medicinal plants to treat their offspring for disease, research by biologists at Emory University shows. Their findings were published online Oct. 6 in the journal Ecology Letters. "We have shown that some species of milkweed, the larva's food plants, can reduce parasite infection in the monarchs," says Jaap de Roode, the evolutionary biologist who led the study. "And we have also found that infected female butterflies prefer to lay their eggs on plants that will make their offspring less sick, suggesting that monarchs have evolved the ...

Colorado Cleantech Industry Association Announces Finalists for Inaugural 'Colorado Cleantech Awards Celebration'

2010-10-11
The Colorado Cleantech Industry Association(CCIA) has released names of the finalists for its inaugural "Colorado Cleantech Awards Celebration" recognition event, honoring leadership in advancing cleantech. "Winners will be announced at our now officially sold-out event on Tuesday, October 19, 11 a.m. to 1 p.m., at the Denver Marriott City Center," Christine Shapard, CCIA Executive Director announces, "We're extremely pleased to share the twenty finalists who emerged from our statewide call for nominations." CCIA - Leadership in Advancing Cleantech Awards - Finalists: * ...

Chasing Arrows Live at Olivia's at the Point

2010-10-11
Chasing Arrows is a group of like-minded musicians that have integrated varied musical influences into a seamless dynamic whole. They have played the last several years up and down the East Coast for numerous enthusiastic audiences while sharing the stage with many notable acts including The Plain White T's, Carbon Leaf, Days Difference, Uh Huh Her and Vertical Horizon to name but a few. And to top it off, they were selected as first runner up for the MTVU Best Music on Campus Woodie Award in a competition that eliminated literally thousands of bands across the nation and ...

Excelsior SEO Helping Small Business Succeed

2010-10-11
Excelsior SEO a Houston, Texas based Search Engine Optimization company announces a new service to help small businesses succeed with their online marketing efforts. The goal of this service is to provide a SEO service that the business needs, at a price the average business owner can afford. The Webpage Optimization Service is intended for small to mid-size companies to help get them noticed by search engines in their local markets. This service optimizes a clients website page for submission to search engines, local directories, and social media sites so that they ...

Houston Custom Home Builder Give Good Maintenance Tips for New Home Buyers

2010-10-11
When a homeowner moves into a new home, everything should be fresh out of the box. All systems should be in good working order and under warranty. However, as Graham Gamble of Houston custom home builder Whitestone Builders, points out, that doesn't mean they should be ignored. Just because you drive a new car off the lot, doesn't mean you never bring it back for maintenance such as oil and filter changes or routine checks. The systems in a new home should demand the same attention. Here are some tips every Houston homeowner should know: 1. YOUR AC/HAVC - Late summer ...

Exhibitor Radio Zeeland DMP Featured at the 2010 Fort Lauderdale International Boat Show

2010-10-11
Florida known as the "Yachting Capital of the World" will host the largest in-water boat show in the world. The 51st International Boat Show will encompass more than 3 million square feet of space, both on land and in water. The show will feature more than a billion dollars' worth of boats, yachts and accessories from every major marine manufacturer including Radio Zeeland DMP, a company known for their cutting edge technology that is setting the standard with easy to use, high quality and reliable products. With offices in Terneuzen, Netherlands and locally in Fort Lauderdale, ...

Board Chair David Meyer to Receive Grauer School NCPC Award

2010-10-11
The Grauer School's Board Chairman David Meyer has been selected by the Grauer Advancement and Development Committee as the recipient of the 2010 Volunteer of the Year Award from the North County Philanthropy Council (NCPC), to be presented at the 23rd Annual Volunteer Awards Luncheon on November 12, 2010, at the California Center for the Arts in Escondido. The award is bestowed upon individuals who devote their time, talent and resources to help others in North County. Meyer commented, "I am truly honored and humbled by the nomination for this award, and I will gladly ...

San Leandro Florist Lynns Floral Designs Celebrates with Anniversary Discount

2010-10-11
Lynn's Floral Designs Florist celebrates its reopening anniversary this month. Last year, San Leandro Bancroft Florist and Lynn's Floral Designs merged together to form one of East Bay's best florist shops, conveniently located in downtown San Leandro. "We pay attention to details in our floral designs which is why our customers say they keep coming back, and we're proud to serve the local community of San Leandro and the East Bay," says Lynn's Floral Designs Owner, Sonia Albanes. In appreciation to those customers and to let new customers find out about Lynn's Floral ...

Invention Licensing Executive at Colossal Concepts Releases Report

2010-10-11
Michelle McGee-Jones, CEO of Colossal Concepts, is keenly aware of the challenge inventors face in finding manufacturers to license their products. While prospecting for executives to approach for her own clients' products, she would sometimes run out of companies to contact. She recently expanded her search, however, and unearthed 27 sources of manufacturer databases and leads—both online and offline, and most with free access. McGee-Jones packaged it into a 5-page report and titled it "Where to Look for Manufacturers to Buy or License Your Invention." The report ...

Technology Featured in Patek Phillippe Watches at Jewels Stores on St. Thomas and St. John in the Caribbean

2010-10-11
Are today's consumers looking for the latest in watchmaking technology when it comes to a luxury purchase? According to Jewels, a luxury jewelry retailer with locations on St. Thomas and St. John in the Caribbean, savvy consumers are seeking timepieces that not only are elegant, but also have the latest generation technology. That's why the stores carry an extensive line of Patek Philippe watches. "Watches essentially are a very personal reflection of both the wearer and the giver," explains Tony Wasserman, Jewels vice president of marketing. "Society as a whole is becoming ...

LAST 30 PRESS RELEASES:

Father’s mental health can impact children for years

Scientists can tell healthy and cancerous cells apart by how they move

Male athletes need higher BMI to define overweight or obesity

How thoughts influence what the eyes see

Unlocking the genetic basis of adaptive evolution: study reveals complex chromosomal rearrangements in a stick insect

Research Spotlight: Using artificial intelligence to reveal the neural dynamics of human conversation

Could opioid laws help curb domestic violence? New USF research says yes

NPS Applied Math Professor Wei Kang named 2025 SIAM Fellow

Scientists identify agent of transformation in protein blobs that morph from liquid to solid

Throwing a ‘spanner in the works’ of our cells’ machinery could help fight cancer, fatty liver disease… and hair loss

Research identifies key enzyme target to fight deadly brain cancers

New study unveils volcanic history and clues to ancient life on Mars

Monell Center study identifies GLP-1 therapies as a possible treatment for rare genetic disorder Bardet-Biedl syndrome

Scientists probe the mystery of Titan’s missing deltas

Q&A: What makes an ‘accidental dictator’ in the workplace?

Lehigh University water scientist Arup K. SenGupta honored with ASCE Freese Award and Lecture

Study highlights gaps in firearm suicide prevention among women

People with medical debt five times more likely to not receive mental health care treatment

Hydronidone for the treatment of liver fibrosis associated with chronic hepatitis B

Rise in claim denial rates for cancer-related advanced genetic testing

Legalizing youth-friendly cannabis edibles and extracts and adolescent cannabis use

Medical debt and forgone mental health care due to cost among adults

Colder temperatures increase gastroenteritis risk in Rohingya refugee camps

Acyclovir-induced nephrotoxicity: Protective potential of N-acetylcysteine

Inhibition of cyclooxygenase-2 upregulates the nuclear factor erythroid 2-related factor 2 signaling pathway to mitigate hepatocyte ferroptosis in chronic liver injury

AERA announces winners of the 2025 Palmer O. Johnson Memorial Award

Mapping minds: The neural fingerprint of team flow dynamics

Patients support AI as radiologist backup in screening mammography

AACR: MD Anderson’s John Weinstein elected Fellow of the AACR Academy

Existing drug has potential for immune paralysis

[Press-News.org] UT Southwestern study to determine whether leptin helps type 1 diabetes patients